UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000061348 |
|---|---|
| Receipt number | R000070189 |
| Scientific Title | Effectiveness of Camouflage Makeup Using Cover Foundation in Patients with Vitiligo: A Study Evaluation |
| Date of disclosure of the study information | 2026/04/22 |
| Last modified on | 2026/04/22 11:29:58 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effectiveness of Camouflage Makeup Using Cover Foundation in Patients with Vitiligo: A Study Evaluation
Acronym
A Study Evaluating the Effectiveness of Camouflage Makeup for Vitiligo
Scientific Title
Effectiveness of Camouflage Makeup Using Cover Foundation in Patients with Vitiligo: A Study Evaluation
Scientific Title:Acronym
A Study Evaluating the Effectiveness of Camouflage Makeup for Vitiligo
Region
| Japan |
Condition
Condition
vitiligo vulgaris
Classification by specialty
| Dermatology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The psychological effects of professional advice by cosmetology specialists using specialized cover foundation in patients with vitiligo were investigated.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The Dermatology Life Quality Index (DLQI) will be used to evaluate improvements in quality of life associated with camouflage makeup.
Assessments will be conducted before the intervention and after two weeks of continued use at home.
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Maneuver |
Interventions/Control_1
Participants will receive camouflage makeup application and instruction from trained cosmetology specialists using a dedicated cover foundation. Based on this guidance, they will perform self-application in daily life and continue use at home for two weeks.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 15 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Disease/site: Vitiligo affecting exposed areas (face, neck, and hands)
Age: 15 years or older; for participants under 18 years of age, parental consent is required
Sex: No restriction
Patients who have provided written informed consent to participate in the study and who attended a dermatology vitiligo clinic seeking camouflage makeup
Key exclusion criteria
History of allergy to cosmetics or presence of allergic reactions
Patients scheduled to undergo additional surgery
Patients who are objectively judged to lack the capacity to provide informed consent
Target sample size
25
Research contact person
Name of lead principal investigator
| 1st name | Takehiro |
| Middle name | |
| Last name | Takahashi |
Organization
Tohoku university hospital
Division name
Dermatology
Zip code
980-8574
Address
1-1 Seiryomachi, Aobaku, Sendai, Miyagi
TEL
022-717-7271
takehiro.takahashi@derma.med.tohoku.ac.jp
Public contact
Name of contact person
| 1st name | Moyuka |
| Middle name | |
| Last name | Irimada |
Organization
Tohoku university hospital
Division name
Dermatology
Zip code
980-8574
Address
1-1 Seiryomachi, Aobaku, Sendai, Miyagi
TEL
022-717-7271
Homepage URL
moyukairimada87@derma.med.tohoku.ac.jp
Sponsor or person
Institute
Tohoku University
Institute
Department
Personal name
Funding Source
Organization
Shiseido Company, Limited
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Committee Tohoku University Graduate School of Medicine
Address
Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan
Tel
022-728-4105
ec-med@grp.tohoku.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 04 | Month | 22 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2026 | Year | 04 | Month | 16 | Day |
Date of IRB
| 2026 | Year | 04 | Month | 16 | Day |
Anticipated trial start date
| 2026 | Year | 04 | Month | 22 | Day |
Last follow-up date
| 2029 | Year | 02 | Month | 28 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 04 | Month | 22 | Day |
Last modified on
| 2026 | Year | 04 | Month | 22 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070189
